June 27, 2023
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform the biomedical research community of the availability of forms to request Helium-3 for FY 2024 that is intended for medical research (such as hyperpolarized MRI). Requests are being accepted now through July 31, 2023.
Request forms and further information may be obtained by emailing the NIH Representative for the DoE Inter-Agency Helium-3 Working Group.
Simhan Danthi, PhD
(NIH Representative for the DoE Inter-Agency Helium-3 Working Group)
Program Director
National Heart, Lung, and Blood Institute (NHLBI)
Division of Cardiovascular Sciences
Telephone: 301-451-5170
Email: [email protected]